Department of Health and Human Services April 3, 2006 – Federal Register Recent Federal Regulation Documents

Advisory Committee on Immunization Practices: Meeting
Document Number: E6-4775
Type: Notice
Date: 2006-04-03
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Proposed Data Collections Submitted for Public Comment and Recommendations
Document Number: E6-4774
Type: Notice
Date: 2006-04-03
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
National Committee on Vital and Health Statistics; Meeting
Document Number: 06-3171
Type: Notice
Date: 2006-04-03
Agency: Department of Health and Human Services
Health Resources and Services Administration; CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment; Meeting
Document Number: 06-3163
Type: Notice
Date: 2006-04-03
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Notice for April 2006 Advisory Committee Meeting
Document Number: 06-3152
Type: Notice
Date: 2006-04-03
Agency: Department of Health and Human Services, Administration for Children and Families, Children and Families Administration
The Secretary of Health and Human Services, by authority of 42 U.S.C. 9836A, section 641A(b) of the Head Start Act, as amended (5 U.S.C. Appendix 2), has formed the Advisory Committee on Head Start Accountabilit5y and Educational Performance Measures (the Committee). The committee is governed by the provisions of Public Law 92-463, as amended (5 U.S.C. Appendix 2). The function of the Committee is to help assess the progress of HHS in developing and implementing educational measures in the Head Start Program. This includes the Head Start National Reporting System (NRS). The Committee is to provide recommendations for integrating NRS with other ongoing assessments of the effectiveness of the program. The Committee will make recommendations as to how NRS and other assessment data can be included in the broader Head Start measurement efforts found in the Family and Child Experiences Survey (FACES), the National Head Start Impact Study, Head Start's Performance Based Outcome System, and the ongoing evaluation of the Early Head Start program.
Ophthalmic and Topical Dosage Form New Animal Drugs; Gentamicin Sulfate, Betamethasone Valerate, Clotrimazole Ointment
Document Number: 06-3149
Type: Rule
Date: 2006-04-03
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental abbreviated new animal drug application (ANADA) filed by Med-Pharmex, Inc. The supplemental ANADA provides for a new container size, a 15-gram bottle, from which gentamicin sulfate, betamethasone valerate, clotrimazole ointment may be dispensed for the treatment of acute and chronic canine otitis externa.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.